EUVIMEDEUVIMED entdecken
Crossref

ZDHHC16-induced GPX2 S-palmitoylation promotes lenvatinib resistance and inhibits lenvatinib-induced immunogenic cell death in hepatocellular carcinoma

Long He, Guangquan Zhang, Yuxiu Sun, Xinli Liu, Yuanming Song, Ziyue Zhang, Tiantian Fu, Tianhe Zhang, Xinlei Wang, Yang Li, Hongwei Yang, Wen Liu und 2 weitere

Drug Resistance Updates · 2026-11 · 89 · 101449

DOI: 10.1016/j.drup.2026.101449 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Resistance Updates, 2026-11. Verfasst von Long He und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organ Transplantation, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China; Organ Transplant Center, Gener…. Hauptthemen laut MEDLINE: Phenylurea Compounds, Quinolines, Drug Resistance, Neoplasm, Liver Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

S-palmitoylation is a common and reversible post-translational modification. This study aims to elucidate the functional role and mechanism of S-palmitoylation in lenvatinib resistance and lenvatinib-induced immunogenic cell death (ICD) in hepatocellular carcinoma (HCC). Using small interfering RNA (siRNA) screening in HCC cells, zinc finger DHHC-type palmitoyltransferase 16 (ZDHHC16) was identified as a lenvatinib resistance-associated palmitoyl acyltransferase. ZDHHC16 was abnormally overexpressed in both lenvatinib-resistant tissues and cells. ZDHHC16 knockdown improved the sensitivity of HCC cells to lenvatinib. Furthermore, ZDHHC16 knockdown boosted lenvatinib-induced ICD of HCC cells, characterized by an increase in the release of danger associated molecular patterns (DAMPs), including calreticulin (CRT) exposure on the tumor cell surface, high mobility group box 1 (HMGB1), annexin A1 (ANXA1), and adenosine-5'-triphosphate (ATP), as well as an increase in reactive oxygen species (ROS) production, endoplasmic reticulum (ER) stress, and the secretion of cytotoxic cytokines (tumor necrosis factor (TNF)-α and interferon (IFN)-γ). Mechanistically, ZDHHC16 catalyzed the S-palmitoylation of glutathione peroxidase 2 (GPX2) at C67, which prevented ubiquitination-proteasome degradation of GPX2, thereby enhancing its protein stability. Targeting the ZDHHC16-mediated GPX2 S-palmitoylation improved lenvatinib-induced ICD and antitumor immunity, thereby enhancing the efficacy of lenvatinib. Collectively, our findings reveal that ZDHHC16-induced GPX2 S-palmitoylation plays a crucial role in modulating lenvatinib resistance and lenvatinib-induced ICD in HCC. Targeting this pathway is a promising approach to improve lenvatinib's antitumor activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phenylurea CompoundsQuinolinesDrug Resistance, NeoplasmLiver NeoplasmsCarcinoma, HepatocellularGlutathione PeroxidaseAcyltransferasesHumansAnimalsImmunogenic Cell DeathAntineoplastic AgentsCell Line, TumorHMGB1 ProteinMiceReactive Oxygen SpeciesGene Expression Regulation, NeoplasticProtein Processing, Post-TranslationalRNA, Small Interfering

Stichwörter der Autor:innen

GPX2Immunogenic cell deathLenvatinib resistanceS-palmitoylationZDHHC16

Substanzen

Phenylurea CompoundsQuinolinesGlutathione PeroxidaseAcyltransferaseslenvatinibAntineoplastic AgentsHMGB1 ProteinReactive Oxygen SpeciesRNA, Small Interfering

Autor:innen und Institutionen

  • Department of Organ Transplantation, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China; Organ Transplant Center, General Hospital of Northern Theater Command, Shenyang, Liaoning 110016, Ch…
  • Department of Hepatobiliary and Pancreatic Surgery, The Eighth Affiliated Hospital of Sun Yat-sen University, Biological Laboratory of Hetao Cooperation Zone, The Eighth Affiliated Hospital of Sun Yat-sen University, Sh…
  • Department of Digestive Diseases 1, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning 110042, China.
  • Department of Digestive Diseases 3, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning 110042, China.
  • Cancer Hospital of China Medical University, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning 110042, China.
  • Dalian Medical University, Dalian, Liaoning 116044, China.

Zitieren

APA

He, L., Zhang, G., Sun, Y., Liu, X., Song, Y., Zhang, Z., Fu, T., Zhang, T., Wang, X., Li, Y., Yang, H., Liu, W., Liu, N., & Wang, Z. (2026). ZDHHC16-induced GPX2 S-palmitoylation promotes lenvatinib resistance and inhibits lenvatinib-induced immunogenic cell death in hepatocellular carcinoma. Drug Resistance Updates, 89, 101449. https://doi.org/10.1016/j.drup.2026.101449

Vancouver

He L, Zhang G, Sun Y, Liu X, Song Y, Zhang Z, et al. ZDHHC16-induced GPX2 S-palmitoylation promotes lenvatinib resistance and inhibits lenvatinib-induced immunogenic cell death in hepatocellular carcinoma. Drug Resistance Updates. 2026;89:101449. doi:10.1016/j.drup.2026.101449

BibTeX
@article{He2026,
  author = {He, Long and Zhang, Guangquan and Sun, Yuxiu and Liu, Xinli and Song, Yuanming and Zhang, Ziyue and Fu, Tiantian and Zhang, Tianhe and Wang, Xinlei and Li, Yang and Yang, Hongwei and Liu, Wen and Liu, Ningning and Wang, Zhe},
  title = {ZDHHC16-induced GPX2 S-palmitoylation promotes lenvatinib resistance and inhibits lenvatinib-induced immunogenic cell death in hepatocellular carcinoma},
  journal = {Drug Resistance Updates},
  year = {2026},
  volume = {89},
  pages = {101449},
  doi = {10.1016/j.drup.2026.101449}
}
Kostenlos starten →